Martin Lukas Selected Research

Martin Lukas Research Topics

11	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2023 - 08/2013
5	Ulcerative Colitis 01/2021 - 08/2013
4	Crohn Disease (Crohn's Disease) 10/2023 - 08/2013
2	Pathologic Constriction (Stenosis) 01/2021 - 01/2019
1	Necrosis 10/2022
1	COVID-19 10/2022
1	Severe Acute Respiratory Syndrome 10/2022
1	Mumps 01/2019
1	Colitis 01/2019
1	Fistula 01/2019
1	Hypersensitivity (Allergy) 01/2019
1	Infections 01/2019
1	Neoplasms (Cancer) 01/2019
1	Abscess 01/2019

5	Infliximab (Remicade)FDA Link 10/2023 - 08/2013
4	Biosimilar PharmaceuticalsIBA 07/2020 - 11/2016
3	VaccinesIBA 10/2022 - 01/2019
3	CT-P13IBA 11/2018 - 11/2016
2	Adalimumab (Humira)FDA Link 07/2020 - 08/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 01/2016
1	Ustekinumab (CNTO 1275)FDA Link 10/2022
1	Methotrexate (Mexate)FDA LinkGeneric 10/2022
1	vedolizumabIBA 10/2022
1	SolutionsIBA 01/2021
1	C-Reactive ProteinIBA 07/2020
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 07/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019
1	Monoclonal AntibodiesIBA 11/2018